Header_Profil.jpg

Recruiting Patients – Fast, Fair, High-Quality

emovis is not only known for its high recruiting numbers. It is also recognized for maintaining and/or exceeding the forecasted study participants recruiting prospects. The reason: emovis demonstrates high-level expertise and is open to innovation when recruiting patients and the Executive Management typically estimates the number of recruits in a conservative manner. A rule of fairness at emovis: Up to now, numerous sponsors were surprised and quite happy.

Search our past trials and recruitment numbers

Start Indication Sponsor Time period Recruited Trial Identifier
2009 Contraception Bayer AG 8 months 148
2009 Diabetes mellitus Novartis 7 months 6
2009 Diabetes mellitus Boehringer Ingelheim 8 months 2
2009 Arthrosis Lilly Deutschland 4 months 12
2009 Diabetes mellitus Lilly Deutschland 2 months 4
2008 Vaccination Merck Sharp & Dohme Corp. 8 months 844
2008 Irritable Bowel Syndrome Menarini 3 months 24
2008 Migraine Merck Sharp & Dohme Corp. 3 months 55
2008 Pain Lilly Deutschland 6 months 12
2008 Diabetes mellitus Merck Sharp & Dohme Corp. 1 month 4
2008 Lipometabolic disorder Merck Sharp & Dohme Corp. 2 months 33
2007 Migraine Merck Sharp & Dohme Corp. 5 months 35
2006 Irritable Bowel Syndrome Glaxo Smith Kline Research & Development Ltd. 3 months 28
2005 Irritable Bowel Syndrome Yamanouchi Pharma 2 months 12
2004 Irritable Bowel Syndrome Glaxo Smith Kline Research & Development Ltd. 5 months 49
2004 Depression Imerem, Schwarz Pharma AG 6 months 5
2004 Depression Lilly Deutschland 3 months 50
2004 Restless Legs Syndrome Boehringer Ingelheim 3 months 49
2004 Polyneuropathy, diabetic INC Research 4 months 19
2003 Depression Dr. Willmar Schwabe 14 months 58
2003 Alzheimer-Disease Sanofi-Synthelabo 15 months 15
2003 Depression H. Lundbeck 7 months 21
2003 Restless Legs Syndrome UCB S.A. 6 weeks 32
2003 Depression Servier Forschung und Pharma-Entwicklung 2 months 24
2003 Alzheimer-Disease Janssen-Cilag 4 months 5
2003 Addiction (Nicotine) Glaxo Smith Kline Research & Development Ltd. 4 days 101
2002 Depression Servier Forschung und Pharma-Entwicklung 3 months 22
2002 Migraine Bayer AG 3 months 10
2002 Migraine Glaxo Smith Kline Research & Development Ltd. 4 months 55
2002 Restless Legs Syndrome Boehringer Ingelheim 3 months 35
2002 Restless Legs Syndrome Glaxo Smith Kline Research & Development Ltd. 3 months 16
2002 Restless Legs Syndrome Glaxo Smith Kline Research & Development Ltd. 2 weeks 9
2002 Schizophrenia Janssen-Cilag 6 months 8
2002 Depression Dr. Willmar Schwabe 10 months 13
2002 Anxiety Disorder (GAD) Orion Pharma 5 months 35
2002 Anxiety Disorder (Phobia) Glaxo Smith Kline Research & Development Ltd. 3 months 25
2001 Depression Servier Forschung und Pharma-Entwicklung 3 months 9
2001 Anxiety Disorder (Panic) Wyeth 12 months 49
2001 Anxiety Disorder (Panic) Pfizer Pharma 3 months 4
2000 Anxiety Disorder (Phobia) Solvay 3 months 23
2000 Depression Boehringer Ingelheim 12 months 60
2017 Irritable Bowel Syndrome Dr. Willmar Schwabe 9 months 23 EudraCT-2014-004702-14
2017 Astellas 1 Monat 22 EudraCT-2014-004996-22
2017 Depression Janssen-Cilag 11 months 12 EudraCT-2016-001929-14
2017 Insomnia Eisai Inc. 10 months 93 EudraCT-2015-004347-39
2017 Vaccination Pfizer Pharma 16 months 26 EudraCT-2016-003866-14
2016 Urinary trakt infections Repha 20 Monate 22 EudraCT-2013-004653-25
2017 Allergic Rhinitis ALK-Abelló 1 Monat 8 EudraCT-2017-000971-97
2017 COPD Astra Zeneca, Pearl 1 Monat 18 EudraCT-2016-000154-34
2017 COPD Verona Pharma 3 Monate 16 EudraCT-2016-005205-40
2017 Acute Infection Medicago 2 months 92
2018 Alzheimer-Disease Eisai Inc. 9 months 13 EudraCT-2016-003928-23
2018 Insomnia Idorsia 12 months 239 EudraCT-2017-004642-20
2018 Acute Infection Medicago 2 Wochen 52 EudraCT-2018-001894-26
2018 Onychomycosis Moberg Pharma 5 Monate 127 EudraCT-2016-001204-39
2018 Premenstrual Syndrome Asarina 6 Monate 20 EudraCT-2017-000822-37
2016 Onychomycosis Almirall 4 Monate 59 EudraCT-2015-000561-31
2015 COPD Novartis 4 Monate 15 EudraCT-2013-003127-11
2013 Depression Allergan 12 Monate 25 EudraCT- 2012-001950-25
2012 COPD Allergan, Almirall, Astra Zeneca 6 Monate 27 EudraCT-2011-001524-38
2011 COPD Glaxo Smith Kline Research & Development Ltd. 6 Monate 20 EudraCT-2010-021802-39
2011 Depression Astra Zeneca 5 Months 18 EudraCT-2010-019925-33
2008 Anxiety Disorder (GAD) H. Lundbeck 3 Monate 10 EudraCT-2008-001766-90
2008 Depression Takeda 8 Monate 28 EudraCT-2008-001580-11
2006 Metrorrhagie Bayer AG 6 Monate 11 EudraCT- 2005-004340-32
2006 Parkinson Disease Axxonis 2 Monate 1 EudraCT-2006-003732-30
2006 Restless Legs Syndrome Boehringer Ingelheim 3 Monate 21 EudraCT-2005-006128-13
2009 Alzheimer-Disease H. Lundbeck 9 Monate 4
2018 Insomnia Janssen-Cilag 4 months 32 EudraCT-2017-000980-33
2017 Psoriasis Novartis 4 Monate 4 EudraCT-2015-005170-38
2017 Lipometabolic disorder Esperion Therapeutics 9 months 4
2008 Diabetes mellitus Lilly Deutschland 4 months 4
2012 Alzheimer-Disease Avraham Pharmaceuticals Ltd. 17 Monate 32 EudraCT-2010-021926-37
2015 Depression Alkermes 5 Monate 14 EudraCT-2014-000380-41
2017 Migraine CoLucid Pharmaceuticals 4 Monate 17 EudraCT-2015-005689-40
2017 Alzheimer-Disease Biogen 18 months 55
2018 Arthrosis Regeneron 2 weeks 23 EudraCT-2017-001702-15
2018 Uterusmyom Bayer AG 8 Months 8 EudraCT-2016-002855-48
2018 Migraine Merck Sharp & Dohme Corp. 2 Months 55
2018 Depression Shire Pharmaceuticals Group Plc 3 Months 29 EudraCT-2015-005282-22
2016 Alzheimer-Disease Pearl, Boehringer Ingelheim 6 months 16 EudraCT-2013-005040-28
2016 Alzheimer-Disease Reckitt Benckiser, Boehringer Ingelheim 1 month 1 EudraCT-2013-005031-24
2018 Insomnia Idorsia 1 month 1 EudraCT-2017-004644-38
2016 Lipometabolic disorder Esperion Therapeutics 6 months 12 EudraCT-2016-004115-12
2018 Depression Janssen-Cilag 3 months 32 EudraCT- 2017-002633-28
2019 Depression Janssen-Cilag 3 months 14 EudraCT-2015-005282-23
2016 Depression Janssen-Cilag 10 months 3
2019 Premenstrual Syndrome Asarina 6 Monate 91 EudraCT-2017-000822-37
2019 Diabetes mellitus Novo Nordisk 4 Monate 14 EudraCT-2017-003219-20
2019 Statin Intoleranz Esperion Therapeutics 4 Months 3 EudraCT2016-003485-11
2019 Irritable Bowel Syndrome Cosmo Pharmaceuticals 4 months 62 EudraCT-2016-004977-42
2019 Obesity Novo Nordisk 3 Months 11 Eudra CT-2017-003380-35
2019 Insomnia Idorsia 4 Months 7 EudraCT-2017-004644-38
2019 Herzinfarkt Novartis 4 Monate 27 EudraCT-2018-003786-34
2014 Vaccination Sanofi-Pasteur 11 months 6
2019 Acute Infection Sanofi-Pasteur 1 month 99 EudraCT-2019-000655-14
2014 Irritable Bowel Syndrome Menarini 6 months 15
2019 Alopecia Areata Pfizer Pharma 3 Months 3 EudraCT-2018-001714-14
2019 Atopic Dermatitis Pfizer Pharma 3 Months 3 EudraCT-2018-003050-24
2013 Vaccination Glaxo Smith Kline Research & Development Ltd. 1 month 16
2019 Hyperhidrosis, Hyperhidrosis Wolff 3 Months 12 EudraCT-2017-004534-29
2013 Obstipation Ferring Pharmaceuticals 6 months 24
2013 COPD Glaxo Smith Kline Research & Development Ltd. 1 week 2
2019 Herpes Genitalis Heidelberg ImmunoTherapeutics 8 Monate 56 EudraCT-2019-000880-26
2019 Psoriasis Pfizer Pharma 8 Monate 5 EudraCT-2018-003051-38
2019 Irritable Bowel Syndrome Repha 7 Monate 4 EudraCT-2019-000245-12
2012 Depression Merck Sharp & Dohme Corp. 10 months 5
2019 Irritable Bowel Syndrome SymbioPharm 7 Monate 6 EudraCT-2018-004626-28
2019 Depression Allergan 7 Monate 4 EudraCT-2018-002782-19
2012 COPD Almirall 5 months 27
2020 Vaccination Vakzine Projekt Management 2 months 156 EudraCT-2019-002706-46
2012 Irritable Bowel Syndrome Laves Arzneimittel 2 years 65
2015 Arthrosis Regeneron 6 months 48
2014 Diabetes mellitus Hanmi 5 months 1 EudraCT-2013-004250-13
2011 ADHS Shire Pharmaceuticals Group Plc 7 months 10
2003 Diabetes mellitus Glaxo Smith Kline Research & Development Ltd. 8 months 5
2011 Diabetes mellitus MetaCure Germany 10 months 3
2011 COPD Glaxo Smith Kline Research & Development Ltd. 9 months 21
2011 Psychiatric diagnosis, others Dr. Willmar Schwabe 4 months 50
2011 Diabetes mellitus Boehringer Ingelheim 15 months 18
2010 Vaccination Sanofi-Pasteur 2 months 108
2010 Obstipation Shire Pharmaceuticals Group Plc 32 months 16
2004 Restless Legs Syndrome Imerem 6 Monate 20 EudraCT-2005-000428-18
2004 Alzheimer-Disease Glaxo Smith Kline Research & Development Ltd. 8 Monate 2 EudraCT-2004-000985-12
2004 Depression Wyeth 3 Monate 27 EudraCT-2004-000562-13
2004 Depression Glaxo Smith Kline Research & Development Ltd. 8 Monate 31
2004 Anxiety Disorder (Phobia) Glaxo Smith Kline Research & Development Ltd. 5 Monate 35 EudraCT-2004-000848-24
2004 Anxiety Disorder (GAD) Lilly Deutschland 10 Monate 14
2005 Depression Glaxo Smith Kline Research & Development Ltd. 2 Monate 1 EudraCT-2004-003803-19
2005 Anxiety Disorder (GAD) Lilly Deutschland 8 Monate 17 EudraCT-2004-002626-22
2005 Depression Boehringer Ingelheim 7 Monate 9
2005 Premenstrual Syndrome Wyeth 8 Monate 3 EudraCT-2004-005173-27
2005 Bronchitis Bionorica 2 Wochen 3 EudraCT-2005-003249-15
2005 Anxiety Disorder (Panic) Elbion 1 Monat 12 EudraCT-2005-005708-17
2006 Restless Legs Syndrome Imerem 2 Monate 12
2006 Depression Glaxo Smith Kline Research & Development Ltd. 3 Monate 21 EudraCT-2006-001877-13
2006 Depression Servier Forschung und Pharma-Entwicklung 3 Monate 46 EudraCT-2004-004009-10
2006 Depression Sanofi-Aventis 4 Monate 42 EudraCT - 2004-002327-41
2006 Restless Legs Syndrome Imerem, Schwarz Pharma AG 2 Monate 11 EudraCT-2004-001589-42
2006 Insomnia Sanofi-Aventis 18 Monate 31 EudraCT- 2005-003082-16
2006 Restless Legs Syndrome Axxonis 10 Monate 26 EudraCT-2004-001589-42
2006 Anxiety Disorder (GAD) Astra Zeneca 9 Monate 7 EudraCT- 2005-005055-18
2006 Depression Astra Zeneca 4 Monate 13 EudraCT- 2005-003745-14
2006 Restless Legs Syndrome Glaxo Smith Kline Research & Development Ltd. 4 Monate 3
2006 Restless Legs Syndrome Boehringer Ingelheim 7 Monate 21 EudraCT-2005-005225-54
2006 Hypertension Astra Zeneca 6 Monate 50 EudraCT -2005-005718-19
2006 Anxiety Disorder (Phobia) Glaxo Smith Kline Research & Development Ltd. 5 Monate 16 EudraCT- 2006-003597-10
2007 Depression Pierre Fabre 5 Monate 11 EudraCT-2006-002404-34
2007 Anxiety Disorder (GAD) Sanofi-Aventis 6 Monate 16 EudraCT 2006-002253-71
2007 Restless Legs Syndrome Boehringer Ingelheim 4 Monate 34 EudraCT-2006-006431-42
2007 Hypertension DaiichiSankyo Deutschland 19 Monate 19 EudraCT-2008-008260-28
2007 Neuralgia (Zoster) Grünenthal 4 Monate 8
2007 Polyneuropathy, diabetic Grünenthal 4 Monate 8 EudraCT-2006-003132-29
2007 Parkinson Disease Imerem 3 Monate 1
2007 Polyneuropathy, diabetic Swedish Orphan 2 Monate 1 EudraCT- 2006-004007-19
2007 Insomnia Sanofi-Aventis 12 Monate 14 EudraCT-2006-006677-25
2007 Depression Servier Forschung und Pharma-Entwicklung 10 Monate 16 EudraCT-2006-004716-48
2007 Depression Sanofi-Aventis 10 Monate 36 EudraCT-2004-002328-16
2007 Depression Glaxo Smith Kline Research & Development Ltd. 10 Monate 36 EudraCT-2005-003400-11
2007 Sexual Dysfunction Boehringer Ingelheim 11 Monate 60 EudraCT-2007-000032-68
2008 Hypertension Takeda 2 Monate 10 EudraCT-2007-002583-10
2008 Sexual Dysfunction Bayer AG 4 Monate 13 Eudract-2006-004397-27
2008 Depression H. Lundbeck 6 Monate 30 EudraCT-2008-001580-11
2008 Depression Sanofi-Aventis 6 Monate 29 EudraCT-2004-002328-16
2008 Overactive Bladder (OAB) Pfizer Pharma 4 Monate 18 EudraCT-2004-000476-13
2008 Vaccination Glaxo Smith Kline Research & Development Ltd. 1 Monat 44
2008 Alzheimer-Disease IFE Europe 1 Monat 3 EudraCT-2008-002758-39
2008 Anxiety Disorder (GAD) Takeda 2 Monate 7 EudraCT-2008-001766-90
2008 Hypertension Novartis 4 Monate 17 EudraCT- 2006-006068-44
2009 Insomnia Glaxo Smith Kline Research & Development Ltd. 2 Monate 29 EudraCT-2008-006345-72
2009 Depression Takeda 1 Monat 49 EudraCT-2008-001581-91
2009 Addiction (Alcohol) Pierrell Research 15 Monate 28 EudraCT-2007-002315-92
2009 Restless Legs Syndrome Pfizer Pharma 6 Monate 16 EudraCT-2008-005889-32
2009 Alzheimer-Disease Servier Forschung und Pharma-Entwicklung 7 Monate 7
2009 Depression H. Lundbeck 2 Monate 6 EudraCT-2007-001871-13
2009 Alzheimer-Disease H. Lundbeck 7 Monate 10
2009 Addiction (Alcohol) H. Lundbeck 10 Monate 121 EudraCT-2007-002315-92
2010 Depression Glaxo Smith Kline Research & Development Ltd. 4 Monate 22 EudraCT- 2009-010339-42
2010 Alzheimer-Disease Lilly Deutschland 9 Monate 4 EudraCT-2008-002758-39
2010 Depression Sanofi-Aventis 7 Monate 33 EudraCT-2009-010339-42
2010 Alzheimer-Disease JSW Lifescience 6 Monate 4
2010 Migraine Symbicort, Merck Sharp & Dohme Corp. 1 Monat 27 EudraCT-2010-019288-13
2010 Depression Analyze & Realize, Leiber 5 Monate 95
2010 Vaccination Glaxo Smith Kline Research & Development Ltd. 2 Monate 40
2010 Prophylaxis (Flu) Analyze & Realize, Leiber 1 Monat 60
2011 Depression Astra Zeneca 5 Monate 18 EudraCT-2010-019925-33
2011 ADHS Novartis 4 Monate 70 EudraCT-2011-004668-31
2011 Hypertension Servier Forschung und Pharma-Entwicklung 6 Monate 25 EudraCT- 2010-020945-28
2011 Depression Takeda 5 Monate 46 EudraCT- 2011-005298-22
2011 Psychiatric diagnosis, others Weleda AG 9 Monate 201 EudraCT- 2010-024189-23
2011 Venous insufficiency OM Pharma (Vifor Pharma) 4 Monate 9 EudraCT-2009-013391-44
2011 Restless Legs Syndrome UCB S.A. 4 Monate 47 EudraCT- 2011-000053-23
2011 Alzheimer-Disease Genetech 4 Monate 6 EudraCT-2010-021926-37
2011 Alzheimer-Disease Avraham Pharmaceuticals Ltd. 17 Monate 32 EudraCT-2010-021926-37
2012 Addiction (Nicotine) Pfizer Pharma 2 Jahre 371 EudraCT- 2010-022914-15
2012 Depression Shire Pharmaceuticals Group Plc 12 Monate 44 EudraCT-2011-003018-17
2012 Depression H. Lundbeck 8 Monate 19 EudraCT-2012-001380-76
2013 Binge Eating Disorder Shire Pharmaceuticals Group Plc 2 Monate 2 Eudra CT-2012-003310-14
2013 COPD Almirall, Astra Zeneca 3 Monate 20 EudraCT-2013-000116-14
2014 Binge Eating Disorder Shire Pharmaceuticals Group Plc 1 Monat 1 EudraCT-2012-004457-88
2014 COPD Novartis 2 Monate 21 EudraCT-2013-001477-25
2014 COPD Glaxo Smith Kline Research & Development Ltd. 6 Wochen 12 EudraCT-2011-005914-12
2014 COPD Glaxo Smith Kline Research & Development Ltd. 2 Monate 15 EudraCT-2014-000611-14
2015 Depression Alkermes 6 Monate 48 EudraCT-2014-000379-14
2015 COPD Astra Zeneca 4 Monate 11 EudraCT-2014-004715-37
2015 Addiction (Nicotine) Philip Morris 1 Monat 28 EudraCT- 2013-002447-29
2015 Fibromyalgia DaiichiSankyo Deutschland 7 Monate 28 EudraCT-2013-005164-26
2015 COPD Pearl 4 Monate 29 EudraCT-2014-004712-10
2016 Acute Infection Vertex 3 Monate 1 EudraCT- 2014-004068-39
2016 Allergy (Grass pollen) Allergopharma 2 Monate 33 EudraCT- 2015-002409-13
2016 Arthrosis PBB Entrepreneur Ltd. 4 Monate 56
2016 Asthma Astra Zeneca 1 Monat 10 EudraCT- 2004-004042-41
2016 Gastrointestinal Reflux Disease (GERD) Reckitt Benckiser 5 Monate 33 EudraCT-2014-005261-69
2015 Diabetes mellitus Astra Zeneca 4 Monate 9 EudraCT-2015-002376-24
2016 Pain Esperion Therapeutics, Boehringer Ingelheim 5 Monate 90 EUdraCT-2015-000404-25
2016 Contraception DaiichiSankyo Deutschland, Estetra SPRL 5 Monate 21 EudraCT-2013-005164-26
2016 COPD Astra Zeneca 3 Monate 31 EudraCT-2015-005444-33
2016 Irritable Bowel Syndrome SymbioPharm 5 Monate 33 EudraCT- 2011-004593-29
2016 Onychomycosis Polichem 5 Monate 60 EudraCT-2015-000561-31
2016 Irritable Bowel Syndrome Colibiogen 4 Monate 11 EudraCT-2011-001743-78